J. Daykin

发表

Thyroxine replacement therapy and circulating lipid concentrations

J. Franklyn, R. Holder, J. Betteridge, 1993, Clinical endocrinology.

Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.

J. Franklyn, M. Gammage, M. Sheppard, 1996, Heart.

An audit of management of differentiated thyroid cancer in specialist and non‐specialist clinic settings

J. Franklyn, R. Holder, J. Watkinson, 2001, Clinical endocrinology.

Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology.

J. Franklyn, R. Holder, J. Watkinson, 1999, Thyroid : official journal of the American Thyroid Association.

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis

J. Franklyn, R. Holder, J. Betteridge, 1994, Clinical endocrinology.

Propylthiouracil and carbimazole associated‐antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves’ disease

J. Franklyn, J. Heward, S. Gough, 2004, Clinical endocrinology.

Long-term thyroxine treatment and bone mineral density

J. Franklyn, R. Holder, D. Heath, 1992, The Lancet.

Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement

J. Franklyn, M. Miller, M. Sheppard, 1996, BMJ.

Age and gender predict the outcome of treatment for Graves' hyperthyroidism.

J. Franklyn, S. Gough, R. Holder, 2000, The Journal of clinical endocrinology and metabolism.

thyroxine therapy and thyrotoxicosis . Cardiac hypertrophy as a result of long-term

J. Franklyn, M. Gammage, M. Sheppard, 2003 .

Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies.

J. Franklyn, J. Heward, S. Gough, 1998, Thyroid : official journal of the American Thyroid Association.

The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine.

J. A. Franklyn, M. Sheppard, J. Daykin, 1992, The Journal of clinical endocrinology and metabolism.

Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules.

J. A. Franklyn, M. Sheppard, J. Daykin, 1993, BMJ.

Sharing of susceptibility loci between autoimmune diseases: lack of association of the insulin gene region with Graves' disease.

J. Franklyn, S. Gough, J. Carr-Smith, 1999, Thyroid : official journal of the American Thyroid Association.

Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.

J. Franklyn, J. Heward, S. Gough, 1998, The Journal of clinical endocrinology and metabolism.

The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.

J. Franklyn, J. Heward, S. Gough, 1999, The Journal of clinical endocrinology and metabolism.

Radioiodine therapy for hyperthyroidism in young patients--perception of risk and use.

J. Franklyn, P. Stewart, M. Sheppard, 1993, The Quarterly journal of medicine.

Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease.

J. Franklyn, J. Heward, S. Gough, 2003, The Journal of clinical endocrinology and metabolism.

Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.

J. Franklyn, S. Gough, A. Allahabadia, 2001, The Journal of clinical endocrinology and metabolism.

Weight gain following treatment of hyperthyroidism

R. Holder, J. A. Franklyn, M. Sheppard, 2001, Clinical endocrinology.

Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.

R. Holder, J. A. Franklyn, M. Sheppard, 1995, QJM : monthly journal of the Association of Physicians.